MHC class II regulation in vivo in the mouse kidney

Microbes and Infection

Volumn 1, Issue 11, 1999, Pages 903-912

  Sims, Tasha N ^a   Halloran, Philip F ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OXAZOLONE; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HOUSEKEEPING GENE; KIDNEY EPITHELIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0032700695     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00227-0     Document Type: Article

References (63)

1. Austyn J.M. New insights into the mobilization and phagocytic activity of dendritic cells. J. Exp. M. 183:1996;1287.
2. Barrett M., Milton A.D., Barrett J. Needle biopsy evaluation of class II major histocompatibility complex antigen expression for the differential diagnosis of cyclosporine nephrotoxicity from kidney graft rejection. Transplantation. 44:1987;223.
3. Belitsky P., Miller S.M., Gupta R., Lee S., Ghose T. Induction of MHC class II expression in recipient tissues caused by allograft rejection. Transplantation. 49:1990;472.
4. Benoist C., Mathis D. Selection for survival? Science. 276:1997;2000.
5. Campos L., Naji A., Deli B.C. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation. 59:1995;187.
6. Chang C.H., Flavell R.A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp M. 181:1995;765.
7. Chang C.H., Guerder S., Hong S.C., VanEwijk W., Flavell R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 4:1996;167.
8. Chang C.H., Fontes J.D., Peterlin M., Flavell R.A. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. M. 180:1994;1367.
9. Cockfield S.M., Ramassar V., Halloran P.F. Regulation of IFN-γ and tumor necrosis factor-a expression in vivo. J. Immunol. 150:1993;342.
10. Cockfield S.M., Urmson J., Pleasants J.R., Halloran P.F. The regulation of expression of MHC products in mice factors determining the level of expression in kidneys of normal mice. J. Immunol. 144:1990;2967.
11. Daar A.S., Fuggle S.V., Fabre J.W., Ting A., Morris P.J. The detailed distribution of MHC class II antigens in normal human organs. Transplantation. 38:1984;293.
12. Denzin L.K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha/beta dimers and facilitates peptide loading. Cell. 82:1995;155.
13. Denzin L.K., Hammond C., Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. M. 184:1996;2153.
14. Douhan III J., Lieberson R., Knoll J.H.M., Zhou H., Glimcher L.H. An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator. J. Exp. M. 185:1997;1885.
15. Escalante C.R., Yie J., Thanos D., Aggarwal A.K. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature. 391:1998;103.
16. Fellstrom B., Klareskog L., Larsson E. Tissue distribution of macrophages, class II transplantation antigens, and receptors for platelet-derived growth factor in normal and rejected human kidneys. Transplant. Proc. 19:1987;3625.
17. Finn P.W., Kara C.J., Van T.T., Douhan III J., Boothby M.R., Glimcher L.H. The presence of a DNA binding complex correlates with E beta class II MHC gene expression. EMBO J. 9:1990;1543.
18. Goes N., Sims T., Urmson J., Vincent D., Ramassar V., Halloran P.F. Disturbed MHC regulation in the interferon-γ knockout mouse. J. Immunol. 155:1995;4559.
19. Goes N., Urmson J., Hobart M., Halloran P.F. The unique role of interferon-γ in the regulation of MHC expression on arterial endothelium. Transplantation. 62:1996;1889.
20. Goes N., Urmson J., Ramassar V., Halloran P.F. Ischemic acute tubular necrosis induces an extensive local cytokine response evidence for induction of interferon-γ, transforming growth factorβ-1, granulocyte-macrophage colony-stimulating factor, interleukin-2 and interleukin-10. Transplantation. 59:1995;565.
21. Goes N., Urmson J., Vincent D., Ramassar V., Halloran P.F. Induction of major histocompatibility complex and inflammatory cytokines after ischemic injury to the kidney Lessons from the interferon-γ gene knockout mice. Transplant. Proc. 27:1995;771.
22. Guardiola J., Maffei A. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. Crit. Rev. Immunol. 13:1993;247.
23. Hagerty D.T. Intercellular adhesion molecule-1 is necessary but not sufficient to activate CD4+ T cells. Discovery of a novel costimulator on kidney tubule cells. J. Immunol. 156:1996;3652.
24. Halloran P.F. Interferon-γ, prototype of the proinflammatory cytokines - importance in activation, suppression, and maintenance of the immune response. Transplant. Proc. 25:1993;10.
25. Halloran P.F., Autenried P., Ramassar V., Urmson J., Cockfield S. Local T cell responses induce widespread MHC expression. Evidence that IFN-γ induces its own expression in remote sites. J. Immunol. 148:1992;3837.
26. Halloran P.F., Goes N., Urmson J. MHC expression in organ transplants lessons from the knock-out mice. Transplant. Proc. 29:1997;1041.
27. Halloran P.F., Jephthah-Ochola J., Urmson J., Farkas S. Systemic immunologic stimuli increase class I and II antigen expression in mouse kidney. J. Immunol. 135:1985;1053.
28. Halloran P.F., Urmson J., Ramassar V., Laskin C., Autenried P. Increased class I and class II MHC products and mRNA in kidneys of MRL-lpr/lpr mice during autoimmune nephritis and inhibition by cyclosporine. J. Immunol. 141:1988;2303.
29. Halloran P.F., Urmson J., Solez K. IFN-γ-induced MHC expression in epithelium of rejecting kidneys may protect the graft against early graft destruction by alloantibody (Abstract). J. Am. Soc. Nephrol. 9:1998;650A.
30. Haverty T.P., Watanabe M., Neilson E.G., Kelly C.J. Protective modulation of class II MHC gene expression in tubular epithelium by target antigen-specific antibodies. Cell-surface directed down-regulation of transcription can influence susceptibility to murine tubulointerstitial nephritis. J. Immunol. 143:1989;1133.
31. Hobart M., Ramassar V., Goes N., Urmson J., Halloran P.F. The induction of class I and II major histocompatibility complex by allogeneic stimulation is dependent on the transcription factor interferon regulatory factor 1 (IRF-1). Observations in IRF-1 knockout mice. Transplantation. 62:1996;1895.
32. Hobart M., Ramassar V., Goes N., Urmson J., Halloran P.F. IFN regulatory factor 1 (IRF-1) plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158:1997;4260.
33. Inaba K., Witmer-Pack M., Inaba M. The tissue distribution of the B7-2 costimulator in mice abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. M. 180:1994;1849.
34. Janeway C.A. Jr, Bottomly K., Babich J. Quantitative variation in Ia antigen expression plays a central role in immune regulation. Immunol. Today. 5:1984;99.
35. Jevnikar A.M., Singer G.G., Coffman T., Glimcher L.H., Rubin-Kelley V.E. Transgenictubular cell expression of class IIIs sufficient to initiate immune renal injury. J. Am. Soc. Nephrol. 3:1993;1972.
36. Katz J.F., Stebbins C., Appella E., Sant A.J. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. M. 184:1996;1747.
37. Kirberg J., Berns A., VonBoehmer H. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J. Exp. M. 186:1997;1269.
38. Konieczny B.T., Dai Z., Elwood E.T. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol. 160:1998;2059.
39. Lennon A.M., Ottone C., Rigaud G. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics. 45:1997;266.
40. Letterio J.J., Geiser A.G., Kulkarni A.B. Autoimmunity associated with TGF-β 1-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98:1996;2109.
41. Mach B., Steimle V., Martinez-Soria E., Reith W. Regulation of MHC class II genes lessons from a disease. Ann. Rev. Immunol. 14:1996;301.
42. Milton A.D., Fabre J.W. Massive induction of donor type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat. J. Exp. M. 161:1985;98.
43. Morris P., Shaman J., Attaya M. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature. 368:1994;551.
44. Muhlethaler-Mottet A., Otten L.A., Steimle V., Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:1997;2851.
45. Natali P.G., Quaranta V., Nicotra M.R., Apollonj C., Pellegrino M.A., Ferrone S. Tissue distribution of Ia-like antigens in different species analysis with monoclonal antibodies. Immunobiology. 169:1985;228.
46. Neuberger M.S. Antigen receptor signaling gives lymphocytes a long life. Cell. 90:1997;971.
47. Ramassar V., Goes N., Hobart M., Halloran P.F. Evidence for the in vivo role of class II transactivator in basal and IFN-γ induced class II expression in mouse tissue. Transplantation. 62:1996;1901.
48. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity. 2:1995;533.
49. Saleem S., Konieczny B.T., Lowry R.P., Baddoura F.K., Lakkis F.G. Acute rejection of vascularized heart allografts in the absence of IFN-γ Transplantation. 62:1996;1908.
50. Sanderson F., Thomas C., Neefjes J., Trowsdale J. Association between HLA-DM and HLA-DR in vivo. Immunity. 4:1996;87.
51. Schwartz R.H. Models of T-cell anergy is there a common molecular mechanism? J. Exp. M. 184:1996;1.
52. Shoskes D., Parfrey N.A., Halloran P.F. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation. 49:1990;201.
53. Shoskes D.A., Halloran P.F. Delayed graft function in renal transplantation etiology, management and long-term significance. J. Urol. 155:1996;1831.
54. Sims T.N., Elliott J.F., Ramassar V., Denney D.W. Jr, Halloran P.F. Mouse CIITA cDNA sequence and amino acid comparison with human CIITA. Immunogenetics. 45:1997;220.
55. Sims T.N., Goes N.B., Ramassar V., Urmson J., Halloran P.F. In vivo class II transactivator expression in mouse is induced by a non-IFN-γ mechanism in response to local injury. Transplantation. 64:1997;1657.
56. Sims T.N., Pahl A., Ramassar V., Halloran P.F. Regulation of LMP7, TAP1 and H2-MA RNA levels in response to IFN-γ and injury in the kidney (Abstract). FASEB J. 12:1998;A590.
57. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome). Cell. 75:1993;135.
58. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science. 265:1994;106.
59. Strutz F., Neilson E.G. The role of lymphocytes in the progression of interstitial disease. Kidney Int. 45:(S45):1994;106.
60. Takei Y., Sims T.N., Halloran P.F. Differential usage of the class II transactivator (CIITA) promoters in vivo (Abstract). Transplantation. 65:1998;S30.
61. Wuthrich R.P., Yui M.A., Mazoujian G., Nabavi N., Glimcher L.H., Kelley V.E. Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis. Am. J. Pathol. 134:1989;45.
62. Zhou H., Glimcher L.H. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity. 2:1995;545.
63. Zhou H., Su H.S., Zhang X., DouhanIii J., Glimcher L.H. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant. J. Immunol. 158:1997;4741.